RSV vaccines for older adults: 2023 ACIP recommendations

FHS
August 1, 2023
10:40 am

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

U.S. government’s next-gen Covid effort gives small biotech up to $433 million

The U.S. government’s “Project Nextgen,” its effort to accelerate and streamline the rapid development of the next generation of Covid vaccines and treatments, said Wednesday

September 27, 2023

Lack of direct comparisons prevents assessment of upadacitinib’s benefit in Crohn’s disease

Like several immunosuppressive biologics, the JAK inhibitor upadacitinib is also approved for the treatment of Crohn’s disease. Commissioned by the Federal Joint Committee (G-BA), the

October 25, 2023

Willie Nelson on his new album, cannabis cookbook, Kris Kristofferson and what makes a good song – The Cannabist

By MARIA SHERMAN, AP Music Writer NEW YORK (AP) — Young musicians looking for longevity would be wise to follow the sensible word of Willie

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.